Rank | Gene Set | Z-score |
---|---|---|
1 | * NIK/NF-kappaB signaling (GO:0038061) | 6.75899657 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.64958391 |
3 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.31952246 |
4 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.29057533 |
5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.01838025 |
6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.01838025 |
7 | response to muramyl dipeptide (GO:0032495) | 4.74236764 |
8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.66016466 |
9 | positive regulation of antigen processing and presentation (GO:0002579) | 4.55112176 |
10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.50542128 |
11 | regulation of RIG-I signaling pathway (GO:0039535) | 4.43231247 |
12 | neutrophil activation involved in immune response (GO:0002283) | 4.38126030 |
13 | negative thymic T cell selection (GO:0045060) | 4.21879801 |
14 | regulation of antigen processing and presentation (GO:0002577) | 4.05784782 |
15 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.04487535 |
16 | negative T cell selection (GO:0043383) | 3.99436286 |
17 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.95501945 |
18 | natural killer cell mediated immunity (GO:0002228) | 3.95501945 |
19 | neutrophil activation (GO:0042119) | 3.91869882 |
20 | positive regulation of interleukin-12 production (GO:0032735) | 3.90025557 |
21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.85234621 |
22 | granulocyte activation (GO:0036230) | 3.83695065 |
23 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.82197453 |
24 | positive regulation of humoral immune response (GO:0002922) | 3.71262997 |
25 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.70349265 |
26 | * myeloid dendritic cell differentiation (GO:0043011) | 3.62549755 |
27 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.61359101 |
28 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.60696835 |
29 | type I interferon signaling pathway (GO:0060337) | 3.58988647 |
30 | cellular response to type I interferon (GO:0071357) | 3.58988647 |
31 | response to type I interferon (GO:0034340) | 3.58645312 |
32 | regulation of gamma-delta T cell activation (GO:0046643) | 3.53106088 |
33 | positive regulation of interleukin-2 production (GO:0032743) | 3.50044386 |
34 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.46809649 |
35 | regulation of interleukin-12 production (GO:0032655) | 3.46471737 |
36 | regulation of necroptotic process (GO:0060544) | 3.45737413 |
37 | response to peptidoglycan (GO:0032494) | 3.44365936 |
38 | detection of other organism (GO:0098543) | 3.43885859 |
39 | growth hormone receptor signaling pathway (GO:0060396) | 3.41716456 |
40 | response to protozoan (GO:0001562) | 3.41179028 |
41 | detection of bacterium (GO:0016045) | 3.38915040 |
42 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.38202326 |
43 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.36825534 |
44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.36176078 |
45 | immunoglobulin mediated immune response (GO:0016064) | 3.35438860 |
46 | * myeloid dendritic cell activation (GO:0001773) | 3.35011451 |
47 | T cell migration (GO:0072678) | 3.34055450 |
48 | positive regulation of interferon-alpha production (GO:0032727) | 3.32519954 |
49 | germinal center formation (GO:0002467) | 3.29850157 |
50 | interferon-gamma secretion (GO:0072643) | 3.28362552 |
51 | positive thymic T cell selection (GO:0045059) | 3.28206313 |
52 | mature B cell differentiation (GO:0002335) | 3.26862226 |
53 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.26805807 |
54 | thymic T cell selection (GO:0045061) | 3.26096961 |
55 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.21640175 |
56 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.21271705 |
57 | regulation of interferon-alpha production (GO:0032647) | 3.19831160 |
58 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.16788634 |
59 | * dendritic cell differentiation (GO:0097028) | 3.15683726 |
60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.14110008 |
61 | regulation of vitamin metabolic process (GO:0030656) | 3.13829075 |
62 | regulation of hypersensitivity (GO:0002883) | 3.13124265 |
63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13001794 |
64 | regulation of T cell tolerance induction (GO:0002664) | 3.12281685 |
65 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.10487583 |
66 | regulation of response to interferon-gamma (GO:0060330) | 3.06526100 |
67 | positive regulation of heat generation (GO:0031652) | 3.05429207 |
68 | cytokine secretion (GO:0050663) | 3.04866759 |
69 | leukocyte aggregation (GO:0070486) | 3.04390421 |
70 | regulation of integrin activation (GO:0033623) | 3.03694776 |
71 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.02950490 |
72 | negative regulation of interleukin-12 production (GO:0032695) | 3.02783592 |
73 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.02127527 |
74 | T cell selection (GO:0045058) | 3.00305942 |
75 | positive regulation of type 2 immune response (GO:0002830) | 2.99705328 |
76 | positive regulation by symbiont of host defense response (GO:0052509) | 2.99329456 |
77 | modulation by symbiont of host defense response (GO:0052031) | 2.99329456 |
78 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.99329456 |
79 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.99329456 |
80 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.99329456 |
81 | modulation by symbiont of host immune response (GO:0052553) | 2.99329456 |
82 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.97818178 |
83 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.96740453 |
84 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95486383 |
85 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.92065331 |
86 | negative regulation of cell killing (GO:0031342) | 2.91787043 |
87 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.91787043 |
88 | positive regulation of T cell cytokine production (GO:0002726) | 2.91750709 |
89 | detection of external biotic stimulus (GO:0098581) | 2.90887865 |
90 | regulation of fever generation (GO:0031620) | 2.90785602 |
91 | cellular response to growth hormone stimulus (GO:0071378) | 2.90102142 |
92 | B cell mediated immunity (GO:0019724) | 2.89005188 |
93 | regulation of podosome assembly (GO:0071801) | 2.88724105 |
94 | negative regulation of necroptotic process (GO:0060546) | 2.87929995 |
95 | T-helper 1 type immune response (GO:0042088) | 2.87301882 |
96 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.86442481 |
97 | lymphocyte migration (GO:0072676) | 2.85522214 |
98 | tolerance induction (GO:0002507) | 2.85109922 |
99 | leukocyte mediated cytotoxicity (GO:0001909) | 2.84460696 |
100 | positive regulation of B cell differentiation (GO:0045579) | 2.84225446 |
101 | regulation of chemokine biosynthetic process (GO:0045073) | 2.82938993 |
102 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.82347321 |
103 | regulation of tolerance induction (GO:0002643) | 2.81824636 |
104 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81750699 |
105 | cellular response to interferon-beta (GO:0035458) | 2.81527533 |
106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.81385789 |
107 | defense response to protozoan (GO:0042832) | 2.81312915 |
108 | regulation of chronic inflammatory response (GO:0002676) | 2.80416261 |
109 | positive regulation of protein oligomerization (GO:0032461) | 2.80006424 |
110 | positive regulation of protein homooligomerization (GO:0032464) | 2.79964453 |
111 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.79314160 |
112 | regulation of cellular extravasation (GO:0002691) | 2.77959163 |
113 | regulation of immunoglobulin secretion (GO:0051023) | 2.77849106 |
114 | lymphocyte mediated immunity (GO:0002449) | 2.76998347 |
115 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.76105372 |
116 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.75531610 |
117 | myeloid cell activation involved in immune response (GO:0002275) | 2.75335248 |
118 | response to interleukin-15 (GO:0070672) | 2.75306543 |
119 | cellular response to interferon-gamma (GO:0071346) | 2.74492925 |
120 | macrophage activation involved in immune response (GO:0002281) | 2.74157296 |
121 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.73490346 |
122 | detection of molecule of bacterial origin (GO:0032490) | 2.72972898 |
123 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72860274 |
124 | modulation by symbiont of host cellular process (GO:0044068) | 2.72839572 |
125 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.72652076 |
126 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.71715422 |
127 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.70235059 |
128 | regulation of type 2 immune response (GO:0002828) | 2.68454101 |
129 | negative regulation of innate immune response (GO:0045824) | 2.68336787 |
130 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.65666423 |
131 | response to interferon-gamma (GO:0034341) | 2.63990500 |
132 | cellular extravasation (GO:0045123) | 2.63777722 |
133 | detection of biotic stimulus (GO:0009595) | 2.60584036 |
134 | response to host immune response (GO:0052572) | 2.59806926 |
135 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.59806926 |
136 | lymphocyte chemotaxis (GO:0048247) | 2.58930675 |
137 | macrophage activation (GO:0042116) | 2.56557791 |
138 | cellular response to lipopolysaccharide (GO:0071222) | 2.54253313 |
139 | regulation of mononuclear cell migration (GO:0071675) | 2.52202267 |
140 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.51628961 |
141 | positive regulation of interferon-beta production (GO:0032728) | 2.51200547 |
142 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.50555263 |
143 | regulation of T-helper cell differentiation (GO:0045622) | 2.50463832 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.22724470 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.29128081 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.00124818 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.25436376 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.17796938 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.07035167 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.84593001 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.81736772 |
9 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.50465439 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.34701888 |
11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.34384620 |
12 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.22800113 |
13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.20977852 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18977236 |
15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.09357304 |
16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.88276156 |
17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76790279 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.75866678 |
19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.74759380 |
20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.45772515 |
21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.28892733 |
22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.27751777 |
23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.20684725 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 2.20437767 |
25 | MYB_26560356_Chip-Seq_TH2_Human | 2.19517090 |
26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.04910554 |
27 | MYB_26560356_Chip-Seq_TH1_Human | 1.93889429 |
28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.92463716 |
29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.91846717 |
30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90083299 |
31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.88089824 |
32 | MYC_22102868_ChIP-Seq_BL_Human | 1.86716432 |
33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86510817 |
34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85147704 |
35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81979630 |
36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.80916964 |
37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70767220 |
38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.68115283 |
39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65836253 |
40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64858127 |
41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61566231 |
42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60029345 |
43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50034474 |
44 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49883685 |
45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48524433 |
46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43701996 |
47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42832048 |
48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42399303 |
49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39354164 |
50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38523877 |
51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37875963 |
52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37047117 |
53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32162975 |
54 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30899883 |
55 | MAF_26560356_Chip-Seq_TH2_Human | 1.29218022 |
56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27922441 |
57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27356754 |
58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24540565 |
59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23855740 |
60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23823215 |
61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20754201 |
62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19790481 |
63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15991727 |
64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15878444 |
65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15819354 |
66 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14620913 |
67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13536189 |
68 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.13146693 |
69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11926008 |
70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11807444 |
71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11328821 |
72 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09913579 |
73 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09913579 |
74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08616880 |
75 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08188050 |
76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08108263 |
77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06865025 |
78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06261560 |
79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05236895 |
80 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00095899 |
81 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99630358 |
82 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99283500 |
83 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98473020 |
84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98023391 |
85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97466491 |
86 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97462861 |
87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96571740 |
88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95978651 |
89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95977778 |
90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92551721 |
91 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92276223 |
92 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.91493619 |
93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91444185 |
94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90557139 |
95 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.90241654 |
96 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86979903 |
97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86713908 |
98 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86663199 |
99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85467493 |
100 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80599192 |
101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.79972675 |
102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79749022 |
103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79461230 |
104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78099471 |
105 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77776721 |
106 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.77351541 |
107 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.77041014 |
108 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75169796 |
109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74951293 |
110 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74055849 |
111 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.73857182 |
112 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73664258 |
113 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.72357264 |
114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71907639 |
115 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71899098 |
116 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.69257793 |
117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.68968218 |
118 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68946318 |
119 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.67526872 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.75730073 |
2 | MP0000685_abnormal_immune_system | 4.22709270 |
3 | MP0003436_decreased_susceptibility_to | 3.24311883 |
4 | * MP0001790_abnormal_immune_system | 3.22942591 |
5 | * MP0005387_immune_system_phenotype | 3.22942591 |
6 | MP0009785_altered_susceptibility_to | 3.18732816 |
7 | MP0001348_abnormal_lacrimal_gland | 3.03469395 |
8 | MP0005000_abnormal_immune_tolerance | 2.98234486 |
9 | * MP0001800_abnormal_humoral_immune | 2.96879912 |
10 | MP0002166_altered_tumor_susceptibility | 2.92011676 |
11 | MP0005671_abnormal_response_to | 2.85841458 |
12 | * MP0002148_abnormal_hypersensitivity_rea | 2.84794595 |
13 | * MP0002452_abnormal_antigen_presenting | 2.75260581 |
14 | * MP0002723_abnormal_immune_serum | 2.62525383 |
15 | MP0002006_tumorigenesis | 2.59602120 |
16 | MP0003303_peritoneal_inflammation | 2.57457057 |
17 | * MP0005025_abnormal_response_to | 2.49582003 |
18 | * MP0002419_abnormal_innate_immunity | 2.44514089 |
19 | * MP0001819_abnormal_immune_cell | 2.40939571 |
20 | * MP0002420_abnormal_adaptive_immunity | 2.38646301 |
21 | MP0006082_CNS_inflammation | 2.37463438 |
22 | MP0002009_preneoplasia | 2.27458129 |
23 | * MP0004510_myositis | 2.23789497 |
24 | MP0003763_abnormal_thymus_physiology | 2.20144089 |
25 | MP0005451_abnormal_body_composition | 2.10933081 |
26 | MP0001853_heart_inflammation | 2.10313806 |
27 | * MP0002405_respiratory_system_inflammati | 2.01387185 |
28 | * MP0005310_abnormal_salivary_gland | 1.98187013 |
29 | * MP0000716_abnormal_immune_system | 1.92596727 |
30 | * MP0002398_abnormal_bone_marrow | 1.91120855 |
31 | * MP0004947_skin_inflammation | 1.88754480 |
32 | MP0002163_abnormal_gland_morphology | 1.88225169 |
33 | * MP0010155_abnormal_intestine_physiology | 1.84460640 |
34 | MP0003724_increased_susceptibility_to | 1.83305283 |
35 | MP0003300_gastrointestinal_ulcer | 1.75316597 |
36 | MP0001346_abnormal_lacrimal_gland | 1.71616851 |
37 | MP0009333_abnormal_splenocyte_physiolog | 1.69824272 |
38 | MP0010352_gastrointestinal_tract_polyps | 1.67541092 |
39 | * MP0001845_abnormal_inflammatory_respons | 1.66542479 |
40 | MP0003448_altered_tumor_morphology | 1.65531730 |
41 | MP0005076_abnormal_cell_differentiation | 1.63508225 |
42 | MP0000569_abnormal_digit_pigmentation | 1.60436959 |
43 | MP0009278_abnormal_bone_marrow | 1.58424008 |
44 | MP0002139_abnormal_hepatobiliary_system | 1.58331799 |
45 | MP0001533_abnormal_skeleton_physiology | 1.55482933 |
46 | MP0002877_abnormal_melanocyte_morpholog | 1.53930820 |
47 | * MP0002429_abnormal_blood_cell | 1.52718262 |
48 | MP0008260_abnormal_autophagy | 1.48670458 |
49 | * MP0002722_abnormal_immune_system | 1.48616322 |
50 | * MP0000689_abnormal_spleen_morphology | 1.48163950 |
51 | * MP0001873_stomach_inflammation | 1.44637342 |
52 | MP0001545_abnormal_hematopoietic_system | 1.38187642 |
53 | MP0005397_hematopoietic_system_phenotyp | 1.38187642 |
54 | MP0008004_abnormal_stomach_pH | 1.35414098 |
55 | MP0005166_decreased_susceptibility_to | 1.33264307 |
56 | MP0003091_abnormal_cell_migration | 1.32435867 |
57 | MP0002998_abnormal_bone_remodeling | 1.30898875 |
58 | MP0000858_altered_metastatic_potential | 1.30583995 |
59 | MP0009764_decreased_sensitivity_to | 1.30572483 |
60 | MP0005464_abnormal_platelet_physiology | 1.30091736 |
61 | MP0002396_abnormal_hematopoietic_system | 1.29529793 |
62 | MP0002933_joint_inflammation | 1.27171719 |
63 | * MP0008469_abnormal_protein_level | 1.23897967 |
64 | MP0003806_abnormal_nucleotide_metabolis | 1.22839407 |
65 | * MP0000703_abnormal_thymus_morphology | 1.21360994 |
66 | MP0008057_abnormal_DNA_replication | 1.19389815 |
67 | MP0003866_abnormal_defecation | 1.17052253 |
68 | * MP0003453_abnormal_keratinocyte_physiol | 1.13542734 |
69 | * MP0002138_abnormal_hepatobiliary_system | 1.13490355 |
70 | * MP0002254_reproductive_system_inflammat | 1.09113480 |
71 | MP0005058_abnormal_lysosome_morphology | 1.08431731 |
72 | MP0009840_abnormal_foam_cell | 1.02058707 |
73 | MP0000465_gastrointestinal_hemorrhage | 0.97252664 |
74 | MP0004808_abnormal_hematopoietic_stem | 0.96646669 |
75 | MP0003566_abnormal_cell_adhesion | 0.96161901 |
76 | * MP0000604_amyloidosis | 0.91444418 |
77 | MP0003656_abnormal_erythrocyte_physiolo | 0.91289190 |
78 | MP0002332_abnormal_exercise_endurance | 0.89633237 |
79 | MP0003828_pulmonary_edema | 0.89158918 |
80 | * MP0002277_abnormal_respiratory_mucosa | 0.87550071 |
81 | MP0005164_abnormal_response_to | 0.87206144 |
82 | * MP0001663_abnormal_digestive_system | 0.86343728 |
83 | MP0010307_abnormal_tumor_latency | 0.84175787 |
84 | MP0006054_spinal_hemorrhage | 0.83738307 |
85 | MP0001851_eye_inflammation | 0.82951695 |
86 | MP0001881_abnormal_mammary_gland | 0.82500993 |
87 | MP0005167_abnormal_blood-brain_barrier | 0.80872976 |
88 | MP0005174_abnormal_tail_pigmentation | 0.79975673 |
89 | MP0003183_abnormal_peptide_metabolism | 0.79967245 |
90 | MP0000490_abnormal_crypts_of | 0.78605230 |
91 | MP0005390_skeleton_phenotype | 0.77684947 |
92 | MP0003172_abnormal_lysosome_physiology | 0.77650989 |
93 | MP0000767_abnormal_smooth_muscle | 0.77381781 |
94 | MP0005379_endocrine/exocrine_gland_phen | 0.75571739 |
95 | MP0000627_abnormal_mammary_gland | 0.75489000 |
96 | MP0003690_abnormal_glial_cell | 0.75065144 |
97 | MP0000371_diluted_coat_color | 0.74114302 |
98 | MP0003045_fibrosis | 0.74094455 |
99 | MP0000343_altered_response_to | 0.73199889 |
100 | MP0000249_abnormal_blood_vessel | 0.72718884 |
101 | MP0001849_ear_inflammation | 0.69370475 |
102 | MP0009763_increased_sensitivity_to | 0.69176695 |
103 | MP0005165_increased_susceptibility_to | 0.69095073 |
104 | MP0003705_abnormal_hypodermis_morpholog | 0.67600195 |
105 | MP0001879_abnormal_lymphatic_vessel | 0.67580716 |
106 | MP0008874_decreased_physiological_sensi | 0.66593140 |
107 | MP0003795_abnormal_bone_structure | 0.65687331 |
108 | MP0002019_abnormal_tumor_incidence | 0.64561009 |
109 | MP0004883_abnormal_blood_vessel | 0.64325188 |
110 | MP0005023_abnormal_wound_healing | 0.64086516 |
111 | MP0001542_abnormal_bone_strength | 0.62992577 |
112 | * MP0002136_abnormal_kidney_physiology | 0.62914100 |
113 | * MP0000609_abnormal_liver_physiology | 0.62573345 |
114 | MP0000733_abnormal_muscle_development | 0.62290675 |
115 | MP0003279_aneurysm | 0.57796155 |
116 | * MP0001216_abnormal_epidermal_layer | 0.57509504 |
117 | MP0005621_abnormal_cell_physiology | 0.57090149 |
118 | MP0003075_altered_response_to | 0.57011732 |
119 | MP0004381_abnormal_hair_follicle | 0.56551761 |
120 | MP0003191_abnormal_cellular_cholesterol | 0.56249335 |
121 | MP0004782_abnormal_surfactant_physiolog | 0.55697841 |
122 | MP0002132_abnormal_respiratory_system | 0.54992890 |
123 | MP0003329_amyloid_beta_deposits | 0.54184680 |
124 | MP0004858_abnormal_nervous_system | 0.54116138 |
125 | MP0009765_abnormal_xenobiotic_induced | 0.50219038 |
126 | MP0000470_abnormal_stomach_morphology | 0.50032276 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.94896102 |
2 | Recurrent fungal infections (HP:0002841) | 5.14398544 |
3 | Recurrent abscess formation (HP:0002722) | 5.02836395 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.94911530 |
5 | Recurrent bacterial skin infections (HP:0005406) | 4.84943504 |
6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.81588148 |
7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.81588148 |
8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.81588148 |
9 | Retrobulbar optic neuritis (HP:0100654) | 4.59887411 |
10 | Optic neuritis (HP:0100653) | 4.59887411 |
11 | Mediastinal lymphadenopathy (HP:0100721) | 4.45591867 |
12 | Orchitis (HP:0100796) | 4.44418756 |
13 | Recurrent cutaneous fungal infections (HP:0011370) | 4.42779569 |
14 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.42779569 |
15 | Myositis (HP:0100614) | 4.42386336 |
16 | Recurrent viral infections (HP:0004429) | 4.26453627 |
17 | Increased IgM level (HP:0003496) | 4.03122308 |
18 | Autoimmune thrombocytopenia (HP:0001973) | 3.92258781 |
19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.89015973 |
20 | Chronic otitis media (HP:0000389) | 3.88118316 |
21 | Recurrent skin infections (HP:0001581) | 3.87259139 |
22 | Stomatitis (HP:0010280) | 3.86095798 |
23 | Abnormality of macrophages (HP:0004311) | 3.78123657 |
24 | Vasculitis (HP:0002633) | 3.71866695 |
25 | Systemic lupus erythematosus (HP:0002725) | 3.70111495 |
26 | Pulmonary infiltrates (HP:0002113) | 3.56480358 |
27 | Increased cerebral lipofuscin (HP:0011813) | 3.46869446 |
28 | Nasal polyposis (HP:0100582) | 3.46206784 |
29 | Loss of speech (HP:0002371) | 3.45138967 |
30 | Gastrointestinal infarctions (HP:0005244) | 3.42199255 |
31 | Dysostosis multiplex (HP:0000943) | 3.40998629 |
32 | Colitis (HP:0002583) | 3.29286182 |
33 | Arterial thrombosis (HP:0004420) | 3.25126542 |
34 | Vacuolated lymphocytes (HP:0001922) | 3.24933211 |
35 | Gingivitis (HP:0000230) | 3.21165245 |
36 | Increased IgE level (HP:0003212) | 3.19660281 |
37 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.17576480 |
38 | Keratoconjunctivitis (HP:0001096) | 3.15133716 |
39 | Pustule (HP:0200039) | 3.15113334 |
40 | Eosinophilia (HP:0001880) | 3.11731729 |
41 | Leukocytosis (HP:0001974) | 3.11143969 |
42 | Inflammation of the large intestine (HP:0002037) | 3.06131184 |
43 | Periodontitis (HP:0000704) | 3.05396890 |
44 | Myocardial infarction (HP:0001658) | 3.04583996 |
45 | Agammaglobulinemia (HP:0004432) | 3.02289957 |
46 | Thrombocytosis (HP:0001894) | 2.98249218 |
47 | Abnormality of T cell number (HP:0011839) | 2.98121919 |
48 | Abnormality of the nasal mucosa (HP:0000433) | 2.96820357 |
49 | Panhypogammaglobulinemia (HP:0003139) | 2.93690870 |
50 | Fatigue (HP:0012378) | 2.93416778 |
51 | Hypergammaglobulinemia (HP:0010702) | 2.92010795 |
52 | Hematochezia (HP:0002573) | 2.87471329 |
53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.86656972 |
54 | Gastrointestinal inflammation (HP:0004386) | 2.84412265 |
55 | Recurrent bronchitis (HP:0002837) | 2.81895852 |
56 | Keratoconjunctivitis sicca (HP:0001097) | 2.77045514 |
57 | Meningitis (HP:0001287) | 2.74550817 |
58 | Cellulitis (HP:0100658) | 2.72182228 |
59 | Disinhibition (HP:0000734) | 2.71368304 |
60 | Interstitial pulmonary disease (HP:0006530) | 2.70402283 |
61 | Granulocytopenia (HP:0001913) | 2.69061191 |
62 | Abnormality of the fingertips (HP:0001211) | 2.65150437 |
63 | Peritonitis (HP:0002586) | 2.65024838 |
64 | Chronic obstructive pulmonary disease (HP:0006510) | 2.64598756 |
65 | Obstructive lung disease (HP:0006536) | 2.64598756 |
66 | Abnormality of eosinophils (HP:0001879) | 2.62546385 |
67 | Hemoptysis (HP:0002105) | 2.61478398 |
68 | Increased serum ferritin (HP:0003281) | 2.61282286 |
69 | Malnutrition (HP:0004395) | 2.60063184 |
70 | Emphysema (HP:0002097) | 2.56732122 |
71 | Abnormality of T cells (HP:0002843) | 2.52805181 |
72 | Chronic diarrhea (HP:0002028) | 2.51777829 |
73 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51054735 |
74 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51054735 |
75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51054735 |
76 | Prostate neoplasm (HP:0100787) | 2.48289337 |
77 | Abnormality of T cell physiology (HP:0011840) | 2.46981851 |
78 | Premature loss of primary teeth (HP:0006323) | 2.46651353 |
79 | T lymphocytopenia (HP:0005403) | 2.43972568 |
80 | Tetraparesis (HP:0002273) | 2.41392779 |
81 | Osteolytic defects of the hand bones (HP:0009699) | 2.41243721 |
82 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.41243721 |
83 | Gastrointestinal stroma tumor (HP:0100723) | 2.40588070 |
84 | Encephalitis (HP:0002383) | 2.37861432 |
85 | Restrictive lung disease (HP:0002091) | 2.37534521 |
86 | Mucopolysacchariduria (HP:0008155) | 2.36106388 |
87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.36106388 |
88 | Gingival bleeding (HP:0000225) | 2.35195665 |
89 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.34891614 |
90 | Purpura (HP:0000979) | 2.34814996 |
91 | Petechiae (HP:0000967) | 2.33853106 |
92 | Axonal loss (HP:0003447) | 2.31849795 |
93 | IgA deficiency (HP:0002720) | 2.30758629 |
94 | Amyloidosis (HP:0011034) | 2.28713073 |
95 | Vertebral compression fractures (HP:0002953) | 2.28521613 |
96 | Basal ganglia calcification (HP:0002135) | 2.25013836 |
97 | Autoimmune hemolytic anemia (HP:0001890) | 2.24111705 |
98 | Nuclear cataract (HP:0100018) | 2.22824601 |
99 | Glomerulonephritis (HP:0000099) | 2.21215628 |
100 | Urticaria (HP:0001025) | 2.20176095 |
101 | Thick nail (HP:0001805) | 2.20119059 |
102 | Cheilitis (HP:0100825) | 2.18930167 |
103 | Gangrene (HP:0100758) | 2.18842426 |
104 | Persistence of primary teeth (HP:0006335) | 2.18333794 |
105 | Osteomyelitis (HP:0002754) | 2.18098643 |
106 | Hydroxyprolinuria (HP:0003080) | 2.17762538 |
107 | Abnormality of proline metabolism (HP:0010907) | 2.17762538 |
108 | Lymphopenia (HP:0001888) | 2.17694458 |
109 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.15539842 |
110 | Anhidrosis (HP:0000970) | 2.14354543 |
111 | Skin ulcer (HP:0200042) | 2.14333889 |
112 | Hepatosplenomegaly (HP:0001433) | 2.13393751 |
113 | Thyroiditis (HP:0100646) | 2.13099268 |
114 | IgG deficiency (HP:0004315) | 2.12889838 |
115 | Joint swelling (HP:0001386) | 2.11741030 |
116 | Chest pain (HP:0100749) | 2.11710988 |
117 | Recurrent pneumonia (HP:0006532) | 2.09950213 |
118 | Recurrent lower respiratory tract infections (HP:0002783) | 2.09800153 |
119 | Neurofibrillary tangles (HP:0002185) | 2.09723517 |
120 | Esophageal varix (HP:0002040) | 2.08978154 |
121 | IgM deficiency (HP:0002850) | 2.07413962 |
122 | Polycythemia (HP:0001901) | 2.06442362 |
123 | Chronic sinusitis (HP:0011109) | 2.05485881 |
124 | Spontaneous hematomas (HP:0007420) | 2.05478588 |
125 | Porencephaly (HP:0002132) | 2.04743264 |
126 | Severe combined immunodeficiency (HP:0004430) | 2.02980636 |
127 | Neuronal loss in central nervous system (HP:0002529) | 2.02974246 |
128 | Combined immunodeficiency (HP:0005387) | 2.02915697 |
129 | Abnormality of iron homeostasis (HP:0011031) | 2.01414916 |
130 | Arthralgia (HP:0002829) | 1.99110695 |
131 | Mutism (HP:0002300) | 1.97313409 |
132 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96926134 |
133 | Abnormality of the pleura (HP:0002103) | 1.96538270 |
134 | Progressive neurologic deterioration (HP:0002344) | 1.93242476 |
135 | Anorexia (HP:0002039) | 1.91241600 |
136 | Hypertensive crisis (HP:0100735) | 1.89874084 |
137 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.89578730 |
138 | Glomerulopathy (HP:0100820) | 1.89031110 |
139 | Pulmonary embolism (HP:0002204) | 1.88110034 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 6.00369895 |
2 | TYK2 | 3.80733748 |
3 | JAK3 | 3.67252811 |
4 | TBK1 | 3.38507330 |
5 | * IKBKB | 3.21490330 |
6 | PRPF4B | 3.17997583 |
7 | MAP3K13 | 3.08989426 |
8 | IKBKE | 3.06879913 |
9 | MAP4K1 | 2.98513205 |
10 | IRAK3 | 2.73793258 |
11 | JAK1 | 2.57218307 |
12 | TAOK2 | 2.54113991 |
13 | IRAK4 | 2.45130014 |
14 | * CHUK | 2.43198136 |
15 | TAOK1 | 2.09872740 |
16 | TXK | 2.06998934 |
17 | FGFR4 | 2.05855923 |
18 | EPHB1 | 1.93219595 |
19 | KIT | 1.81507240 |
20 | RIPK4 | 1.76575168 |
21 | EPHA3 | 1.75240619 |
22 | BLK | 1.64819199 |
23 | SMG1 | 1.61714113 |
24 | TRIB3 | 1.56385505 |
25 | ZAP70 | 1.52481695 |
26 | RPS6KA4 | 1.52410652 |
27 | SIK1 | 1.49500851 |
28 | MST4 | 1.46759739 |
29 | DDR2 | 1.39295710 |
30 | FGFR3 | 1.37872087 |
31 | PIM1 | 1.37165543 |
32 | GRK7 | 1.34176210 |
33 | CSF1R | 1.32424427 |
34 | STK10 | 1.27069822 |
35 | CDC42BPA | 1.26693397 |
36 | NLK | 1.26409342 |
37 | PIM2 | 1.25509286 |
38 | SYK | 1.23005947 |
39 | MAP3K10 | 1.21610727 |
40 | JAK2 | 1.21489148 |
41 | CSK | 1.20026413 |
42 | BTK | 1.15676017 |
43 | LCK | 1.14367780 |
44 | CDK12 | 1.11079879 |
45 | IRAK2 | 1.08664055 |
46 | PTK6 | 1.06769908 |
47 | FES | 1.06392028 |
48 | FLT3 | 1.04934391 |
49 | TEC | 1.01193046 |
50 | HCK | 0.99975366 |
51 | GRK6 | 0.98042265 |
52 | ITK | 0.94060272 |
53 | PKN1 | 0.91434531 |
54 | TGFBR2 | 0.90206710 |
55 | IRAK1 | 0.90016471 |
56 | TNK2 | 0.87867145 |
57 | NEK9 | 0.85518257 |
58 | MAP3K3 | 0.85159157 |
59 | PRKAA2 | 0.84336266 |
60 | TESK2 | 0.82485760 |
61 | NME2 | 0.81882915 |
62 | TAOK3 | 0.81585975 |
63 | BMX | 0.79909285 |
64 | EIF2AK2 | 0.77236396 |
65 | ERN1 | 0.75018287 |
66 | FGR | 0.71806346 |
67 | MAPKAPK2 | 0.71136242 |
68 | RPS6KA5 | 0.70728274 |
69 | LRRK2 | 0.69799286 |
70 | ICK | 0.69689001 |
71 | PRKD2 | 0.67456427 |
72 | LYN | 0.66386435 |
73 | MAP3K5 | 0.64854442 |
74 | STK4 | 0.64297588 |
75 | MAP2K3 | 0.63558056 |
76 | TTN | 0.61352919 |
77 | ABL2 | 0.61130626 |
78 | BMPR2 | 0.60380912 |
79 | MARK2 | 0.59669915 |
80 | MARK3 | 0.57324762 |
81 | PRKCQ | 0.56235065 |
82 | ARAF | 0.55677735 |
83 | MAPK7 | 0.54981943 |
84 | MAP2K2 | 0.53603077 |
85 | PDPK1 | 0.52082812 |
86 | ABL1 | 0.51510080 |
87 | RPS6KL1 | 0.51001898 |
88 | RPS6KC1 | 0.51001898 |
89 | RPS6KA1 | 0.50966128 |
90 | MAP3K11 | 0.50562985 |
91 | PDK1 | 0.48672069 |
92 | STK3 | 0.47907991 |
93 | PRKCD | 0.46048589 |
94 | TESK1 | 0.45847958 |
95 | EGFR | 0.44196045 |
96 | PAK4 | 0.43880987 |
97 | RIPK1 | 0.42663795 |
98 | TYRO3 | 0.41587753 |
99 | MAPK4 | 0.41240106 |
100 | MAPK11 | 0.41172581 |
101 | MOS | 0.39309640 |
102 | STK24 | 0.39185178 |
103 | MAP3K8 | 0.38704304 |
104 | CDK9 | 0.36035382 |
105 | TRPM7 | 0.35563427 |
106 | INSR | 0.34747205 |
107 | SIK2 | 0.34488862 |
108 | MELK | 0.34122508 |
109 | NUAK1 | 0.33101460 |
110 | CDK4 | 0.32556020 |
111 | MAP2K6 | 0.32395392 |
112 | MAPK12 | 0.31503900 |
113 | KSR2 | 0.31397910 |
114 | DYRK1B | 0.31358893 |
115 | ALK | 0.30977669 |
116 | MATK | 0.30791865 |
117 | GSK3A | 0.30782340 |
118 | SIK3 | 0.30275335 |
119 | CLK1 | 0.29863752 |
120 | PDGFRA | 0.29543670 |
121 | MAP3K7 | 0.29406856 |
122 | HIPK2 | 0.29374635 |
123 | MAP3K1 | 0.29278854 |
124 | RPS6KA6 | 0.29082383 |
125 | KDR | 0.27370958 |
126 | RPS6KA2 | 0.25853737 |
127 | MST1R | 0.23312236 |
128 | PDGFRB | 0.23016133 |
129 | CDK6 | 0.22899986 |
130 | AKT1 | 0.20332148 |
131 | MAPK3 | 0.20082474 |
132 | TGFBR1 | 0.19976988 |
133 | PRKG2 | 0.19268462 |
134 | RAF1 | 0.18943629 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.47135402 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.02188098 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 2.90779877 |
4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.72752099 |
5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.71463523 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.67536393 |
7 | Measles_Homo sapiens_hsa05162 | 2.49021491 |
8 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.39135437 |
9 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37442419 |
10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.33665265 |
11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.26046880 |
12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.23338771 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.22936991 |
14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.17522157 |
15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.08401846 |
16 | Toxoplasmosis_Homo sapiens_hsa05145 | 2.06712046 |
17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96871291 |
18 | Legionellosis_Homo sapiens_hsa05134 | 1.91046815 |
19 | Apoptosis_Homo sapiens_hsa04210 | 1.88922179 |
20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.81219098 |
21 | Influenza A_Homo sapiens_hsa05164 | 1.80908279 |
22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.77866314 |
23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.77061911 |
24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.68899923 |
25 | Asthma_Homo sapiens_hsa05310 | 1.65617039 |
26 | Tuberculosis_Homo sapiens_hsa05152 | 1.56937921 |
27 | Pertussis_Homo sapiens_hsa05133 | 1.53822476 |
28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51932770 |
29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.51603267 |
30 | Malaria_Homo sapiens_hsa05144 | 1.50442691 |
31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.49575258 |
32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.48256265 |
33 | Shigellosis_Homo sapiens_hsa05131 | 1.40577779 |
34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34458121 |
35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33724505 |
36 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.31240112 |
37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28735528 |
38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28653452 |
39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27700254 |
40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27438505 |
41 | Hepatitis B_Homo sapiens_hsa05161 | 1.26305762 |
42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.24674984 |
43 | Hepatitis C_Homo sapiens_hsa05160 | 1.18059705 |
44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16783262 |
45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.16402910 |
46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14717726 |
47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14154980 |
48 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.12043438 |
49 | Salmonella infection_Homo sapiens_hsa05132 | 1.10506465 |
50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08339326 |
51 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07253224 |
52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97655902 |
53 | Prion diseases_Homo sapiens_hsa05020 | 0.96980194 |
54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95547622 |
55 | Bladder cancer_Homo sapiens_hsa05219 | 0.95175409 |
56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93515225 |
57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86242888 |
58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85487348 |
59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85214873 |
60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82304671 |
61 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.76599745 |
62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70220534 |
63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69067231 |
64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66515042 |
65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.63291318 |
66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60834799 |
67 | Amoebiasis_Homo sapiens_hsa05146 | 0.60259962 |
68 | Lysosome_Homo sapiens_hsa04142 | 0.53884524 |
69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50691808 |
70 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49861268 |
71 | Insulin resistance_Homo sapiens_hsa04931 | 0.49853218 |
72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48878229 |
73 | Phagosome_Homo sapiens_hsa04145 | 0.48730172 |
74 | Platelet activation_Homo sapiens_hsa04611 | 0.48161917 |
75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47625308 |
76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45842837 |
77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44376315 |
78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41511156 |
79 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40931251 |
80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39766044 |
81 | Prostate cancer_Homo sapiens_hsa05215 | 0.39524168 |
82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38152554 |
83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37795741 |
84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37077199 |
85 | Adherens junction_Homo sapiens_hsa04520 | 0.36684610 |
86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36257307 |
87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35951977 |
88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34550865 |
89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33561914 |
90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33363822 |
91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32487314 |
92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31910407 |
93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31702937 |
94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30625669 |
95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30575344 |
96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30083478 |
97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27363055 |
98 | Endocytosis_Homo sapiens_hsa04144 | 0.26832572 |
99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26419341 |
100 | Focal adhesion_Homo sapiens_hsa04510 | 0.25595802 |
101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25032116 |
102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24542460 |
103 | Colorectal cancer_Homo sapiens_hsa05210 | 0.21347703 |
104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20353327 |
105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20103642 |
106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19784864 |
107 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.19261751 |
108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19234946 |
109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17245835 |
110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.16889727 |
111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.16387319 |
112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.15588704 |
113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.15307358 |
114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.12871508 |
115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.12049852 |